# Evaluation of Abemaciclib and Radiation Therapy Before Surgery for the Treatment of High-Risk Adipocytic Retroperitoneal Sarcoma

> **NCT06025747** · PHASE1 · RECRUITING · sponsor: **University of Washington** · enrollment: 18 (estimated)

## Conditions studied

- Retroperitoneal Sarcoma

## Interventions

- **DRUG:** Abemaciclib
- **PROCEDURE:** Computed Tomography
- **PROCEDURE:** Magnetic Resonance Imaging
- **RADIATION:** Radiation Therapy
- **PROCEDURE:** Therapeutic Surgical Procedure

## Key facts

- **NCT ID:** NCT06025747
- **Lead sponsor:** University of Washington
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-03-19
- **Primary completion:** 2027-03-03
- **Final completion:** 2029-03-03
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2026-03-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06025747

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06025747, "Evaluation of Abemaciclib and Radiation Therapy Before Surgery for the Treatment of High-Risk Adipocytic Retroperitoneal Sarcoma". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT06025747. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*